You are here

COPD

GSK and Theravance Announce Start of Phase III Lung Function Study With 'Closed' Triple Combination Treatment FF/UMEC/VI for COPD

Yahoo

Mon, 02/9/15 - 08:18 am

fluticasone furoate/umeclidinium/vilanterol

GSK Expands Portfolio of Asthma/COPD Medicines in U.S.

Drug Discovery and Development

Mon, 01/26/15 - 06:53 pm

Incruse Ellipta

Arnuity Ellipta

Novartis Seeks U.S. Approval for Two COPD Drugs

Bloomberg

Thu, 01/8/15 - 08:00 am

Britain's Vectura collaborates with Janssen in asthma, COPD

Yahoo/Reuters

Tue, 01/6/15 - 08:44 am

Anoro Ellipta beats Spiriva HandiHaler in COPD trial

Seeking Alpha

Fri, 10/17/14 - 10:12 am

Spiriva HandiHaler

Boehringer Ingelheim

Boehringer Ingelheim Announces FDA Approval of Spiriva® Respimat® for the Maintenance Treatment of COPD

Marketwatch

Thu, 09/25/14 - 08:59 am

Boehringer Ingelheim

Boehringer's next-gen COPD treatment hits the mark in Phase III

Fierce Biotech

Tue, 09/9/14 - 10:26 am

Boehringer Ingelheim

AstraZeneca's self-styled 'blockbuster' benralizumab tanks in severe COPD study

Fierce Biotech

Mon, 09/8/14 - 07:55 am

GSK gets a lift as Express Scripts reinstates lung drug Advair

Yahoo/Reuters

Mon, 08/4/14 - 11:41 am

Express Scripts

FDA approves Boehringer's once-a-day inhaler drug

Yahoo/AP

Thu, 07/31/14 - 03:58 pm

Boehringer Ingelheim

Striverdi Respimat

GSK, Theravance announce positive data from two phase III studies

The Fly on the Wall

Wed, 06/11/14 - 09:06 am

Novartis, Boehringer vie for COPD market share with combo meds

Fierce Biotech

Thu, 05/22/14 - 11:57 am

Boehringer Ingelheim

GlaxoSmithKline reports positive data from Incruse Ellipta study

The Fly on the Wall

Tue, 05/20/14 - 09:14 am

Incruse Ellipta

GSK receives approval for Incruse™ Ellipta® (umeclidinium) in the US for the treatment of COPD

Marketwatch

Thu, 05/1/14 - 10:03 am

Incruse Ellipta

GSK, Theravance announce Anoro Ellipta available in U.S. for treatment of COPD

The Fly on the Wall

Mon, 04/28/14 - 08:50 am

Novartis INSTEAD study for Onbrez Breezhaler meets primary objective

Yahoo/Fly on the Wall

Fri, 04/25/14 - 08:14 am

Onbrez Breezhaler

Almirall Drops on U.S. Regulator’s Scrutiny of Lung Drug

Bloomberg

Wed, 04/9/14 - 11:28 am

GlaxoSmithKline's COPD drug Anoro receives European green light

Reuters

Thu, 02/20/14 - 08:44 am

Glaxo’s Advair Loses U.S. Market Share to Astra, Merck

Bloomberg

Tue, 02/4/14 - 06:54 pm

Here's How Forest Laboratories, Inc. is Surviving in the Post Lexapro World

Motley Fool

Mon, 01/27/14 - 12:06 pm

Pages